The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression
- 28 February 2013
- journal article
- Published by Elsevier BV in Psychoneuroendocrinology
- Vol. 38 (2), 209-218
- https://doi.org/10.1016/j.psyneuen.2012.05.017
Abstract
No abstract availableKeywords
Funding Information
- Netherlands Organization for Health Research and Development (10-000-1002)
- Netherlands Institute for Health Services Research (NIVEL)
- Netherlands Institute of Mental Health and Addiction (Trimbos)
This publication has 69 references indexed in Scilit:
- Anti-depressant medication use and C-reactive protein: Results from two population-based studiesBrain, Behavior, and Immunity, 2010
- Longitudinal Evidence for Unfavorable Effects of Antidepressants on Heart Rate VariabilityBiological Psychiatry, 2010
- The impact of sleep disturbances on adipocyte function and lipid metabolismBest Practice & Research Clinical Endocrinology & Metabolism, 2010
- Cardiovascular disease in persons with depressive and anxiety disordersJournal of Affective Disorders, 2010
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- Salivary cortisol, serum lipids, and adiposity in patients with depressive and anxiety disordersMetabolism, 2009
- The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatientsJournal of Behavioral Medicine, 2009
- Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart DiseaseJAMA, 2008
- Hypercortisolemic depression is associated with the metabolic syndrome in late-lifePsychoneuroendocrinology, 2007
- The Corticosteroid Receptor Hypothesis of DepressionNeuropsychopharmacology, 2000